Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Despite living in a wired world, physicians have been slow to adopt e-mail as a way to interact with patients, although this may change as younger, more tech-savvy doctors join the profession.
Doctors may have good reasons to be wary, not only because time spent corresponding by e-mail takes away from more important professional activities and is not billable, but also because a text message or e-mail may be misinterpreted or be seen by unintended eyes, thus expanding a physician's potential legal liability. For those who do decide to use electronic means to communicate with patients, prior planning and the use of certain precautions may allow them to limit their exposure to liability while meeting the needs of the tech savvy modern patient.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
Why is it that those who are best skilled at advocating for others are ill-equipped at advocating for their own skills and what to do about it?
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
Active reading comprises many daily tasks lawyers engage in, including highlighting, annotating, note taking, comparing and searching texts. It demands more than flipping or turning pages.
With trillions of dollars to keep watch over, the last thing we need is the distraction of costly litigation brought on by patent assertion entities (PAEs or "patent trolls"), companies that don't make any products but instead seek royalties by asserting their patents against those who do make products.